O	0	10	Comparison
O	11	13	of
B-Characteristic	14	21	macular
I-Characteristic	22	25	and
I-Characteristic	26	39	peripapillary
I-Characteristic	40	52	measurements
O	53	56	for
O	57	60	the
O	61	70	detection
O	71	73	of
B-Disease	74	82	glaucoma
O	82	83	:
O	84	86	an
B-Diagnostic_tool	87	94	optical
I-Diagnostic_tool	95	104	coherence
I-Diagnostic_tool	105	115	tomography
O	116	121	study
O	121	122	.

O	124	126	To
O	127	135	evaluate
B-Characteristic	136	143	macular
I-Characteristic	144	149	nerve
I-Characteristic	150	155	fiber
I-Characteristic	156	161	layer
I-Characteristic	162	163	(
I-Characteristic	163	166	NFL
I-Characteristic	166	167	)
I-Characteristic	168	177	thickness
O	178	180	in
B-Symptom	181	193	glaucomatous
I-Symptom	194	200	damage
O	201	203	by
B-Diagnostic_tool	204	211	optical
I-Diagnostic_tool	212	221	coherence
I-Diagnostic_tool	222	232	tomography
O	233	234	(
B-Diagnostic_tool	234	237	OCT
O	237	238	)
O	239	242	and
O	243	245	to
O	246	253	compare
O	254	257	its
O	258	272	discriminating
O	273	278	power
O	279	282	for
B-Disease	283	291	glaucoma
O	292	295	and
B-Disease	296	304	glaucoma
I-Disease	305	313	suspects
O	314	318	with
O	319	323	that
O	324	326	of
B-Characteristic	327	332	total
I-Characteristic	333	340	macular
I-Characteristic	341	350	thickness
O	351	354	and
B-Characteristic	355	368	peripapillary
I-Characteristic	369	372	NFL
I-Characteristic	373	382	thickness
O	382	383	.

O	384	389	Cross
O	389	390	-
O	390	399	sectional
O	399	400	,
O	401	405	case
O	405	406	-
O	406	413	control
O	413	414	,
O	415	426	comparative
O	427	432	study
O	432	433	.

O	434	435	A
O	436	441	total
O	442	444	of
O	445	448	133
B-Anatomy	449	453	eyes
O	454	458	from
O	459	462	133
O	463	471	subjects
O	472	481	including
O	482	484	46
O	485	491	normal
B-Anatomy	492	496	eyes
O	496	497	,
O	498	500	48
B-Disease	501	509	glaucoma
I-Disease	509	510	-
I-Disease	510	517	suspect
B-Anatomy	518	522	eyes
O	522	523	,
O	524	527	and
O	528	530	39
B-Disease	531	539	glaucoma
B-Anatomy	540	544	eyes
O	545	549	were
O	550	558	enrolled
O	558	559	.

B-Characteristic	560	567	Macular
I-Characteristic	568	571	NFL
I-Characteristic	572	581	thickness
O	581	582	,
B-Characteristic	583	588	total
I-Characteristic	589	596	macular
I-Characteristic	597	606	thickness
O	606	607	,
O	608	611	and
B-Characteristic	612	625	peripapillary
I-Characteristic	626	629	NFL
I-Characteristic	630	639	thickness
O	640	644	were
O	645	653	measured
O	654	656	by
B-Diagnostic_tool	657	664	Stratus
I-Diagnostic_tool	665	668	OCT
O	669	671	in
O	672	676	each
O	677	687	diagnostic
O	688	693	group
O	693	694	.

O	695	698	The
O	699	707	patterns
O	708	711	and
O	712	724	measurements
O	725	727	of
B-Characteristic	728	735	macular
I-Characteristic	736	739	NFL
I-Characteristic	739	740	,
I-Characteristic	741	746	total
I-Characteristic	747	754	macular
I-Characteristic	754	755	,
I-Characteristic	756	759	and
I-Characteristic	760	773	peripapillary
I-Characteristic	774	777	NFL
I-Characteristic	778	787	thickness
O	788	790	in
O	791	796	total
O	797	801	mean
O	801	802	,
O	803	804	4
O	805	814	quadrants
O	814	815	,
O	816	819	and
O	820	822	12
O	823	828	clock
O	829	834	hours
O	834	835	.

O	836	839	The
O	840	854	discriminating
O	855	860	power
O	861	863	of
O	864	868	each
O	869	878	parameter
O	879	882	for
O	883	892	detection
O	893	895	of
B-Disease	896	904	glaucoma
I-Disease	905	913	suspects
O	914	917	and
B-Disease	918	926	glaucoma
O	927	930	was
O	931	940	evaluated
O	941	943	by
O	944	949	areas
O	950	955	under
O	956	959	the
O	960	968	receiver
O	969	978	operating
O	979	993	characteristic
O	994	999	curve
O	1000	1001	(
O	1001	1005	AROC
O	1005	1006	)
O	1006	1007	.

O	1008	1022	Correspondence
O	1023	1027	with
B-Characteristic	1028	1034	visual
I-Characteristic	1035	1040	field
I-Characteristic	1041	1049	function
O	1050	1053	was
O	1054	1061	studied
O	1062	1064	by
O	1065	1071	linear
O	1072	1082	regression
O	1083	1091	analysis
O	1091	1092	.

O	1093	1096	The
B-Characteristic	1097	1104	macular
I-Characteristic	1105	1108	NFL
I-Characteristic	1109	1116	profile
O	1117	1126	exhibited
O	1127	1128	a
O	1129	1135	double
O	1135	1136	-
O	1136	1140	hump
O	1141	1148	pattern
O	1149	1153	with
O	1154	1159	peaks
O	1160	1164	over
B-Anatomy	1165	1176	superonasal
I-Anatomy	1177	1180	and
I-Anatomy	1181	1192	inferonasal
I-Anatomy	1193	1200	sectors
O	1200	1201	.

O	1202	1203	A
O	1204	1215	significant
O	1216	1226	difference
O	1227	1229	in
B-Characteristic	1230	1237	macular
I-Characteristic	1238	1241	NFL
I-Characteristic	1242	1251	thickness
O	1252	1259	between
O	1260	1266	normal
O	1267	1270	and
B-Disease	1271	1279	glaucoma
I-Disease	1279	1280	-
I-Disease	1280	1287	suspect
O	1288	1294	groups
O	1295	1298	was
O	1299	1304	found
O	1305	1307	at
O	1308	1311	the
O	1312	1313	6
O	1313	1314	-
O	1314	1315	o
O	1315	1316	'
O	1316	1321	clock
O	1322	1330	position
O	1330	1331	,
O	1332	1339	whereas
O	1340	1341	a
O	1342	1352	difference
O	1353	1356	was
O	1357	1362	found
O	1363	1365	in
O	1366	1369	all
O	1370	1376	except
O	1377	1380	the
O	1381	1389	temporal
O	1390	1395	clock
O	1396	1401	hours
O	1402	1409	between
O	1410	1416	normal
O	1417	1420	and
B-Disease	1421	1429	glaucoma
O	1430	1438	subjects
O	1438	1439	.

O	1440	1442	No
O	1443	1454	significant
O	1455	1465	difference
O	1466	1468	in
O	1469	1474	AROCs
O	1475	1478	for
O	1479	1488	detection
O	1489	1491	of
B-Disease	1492	1500	glaucoma
I-Disease	1501	1509	suspects
O	1510	1512	or
B-Disease	1513	1521	glaucoma
O	1522	1525	was
O	1526	1531	found
O	1532	1536	when
B-Characteristic	1537	1544	macular
I-Characteristic	1545	1548	NFL
I-Characteristic	1549	1558	thickness
O	1559	1562	and
B-Characteristic	1563	1568	total
I-Characteristic	1569	1576	macular
I-Characteristic	1577	1586	thickness
O	1587	1599	measurements
O	1600	1604	were
O	1605	1613	compared
O	1613	1614	.

O	1615	1622	However
O	1622	1623	,
B-Characteristic	1624	1628	mean
I-Characteristic	1629	1636	macular
I-Characteristic	1637	1640	NFL
I-Characteristic	1641	1650	thickness
O	1651	1663	demonstrated
O	1664	1665	a
O	1666	1674	stronger
O	1675	1686	correlation
O	1687	1691	with
B-Characteristic	1692	1698	visual
I-Characteristic	1699	1707	function
O	1708	1712	than
B-Characteristic	1713	1717	mean
I-Characteristic	1718	1725	macular
I-Characteristic	1726	1735	thickness
O	1736	1737	(
O	1737	1738	r
O	1739	1740	=
O	1741	1742	0
O	1742	1743	.
O	1743	1745	39
O	1745	1746	/
O	1746	1748	R2
O	1749	1750	=
O	1751	1752	0
O	1752	1753	.
O	1753	1755	15
O	1756	1758	vs
O	1758	1759	.
O	1760	1761	r
O	1762	1763	=
O	1764	1765	0
O	1765	1766	.
O	1766	1768	23
O	1768	1769	/
O	1769	1771	R2
O	1772	1773	=
O	1774	1775	0
O	1775	1776	.
O	1776	1778	05
O	1778	1779	,
O	1780	1781	P
O	1782	1783	=
O	1783	1784	0
O	1784	1785	.
O	1785	1788	042
O	1788	1789	)
O	1789	1790	.

O	1791	1796	Among
O	1797	1800	all
O	1801	1804	the
O	1805	1813	findings
O	1813	1814	,
B-Characteristic	1815	1823	inferior
I-Characteristic	1824	1837	peripapillary
I-Characteristic	1838	1841	NFL
I-Characteristic	1842	1851	thickness
O	1852	1855	had
O	1856	1859	the
O	1860	1864	best
O	1865	1876	performance
O	1877	1879	in
O	1880	1894	discriminating
B-Disease	1895	1903	glaucoma
O	1904	1905	(
O	1905	1909	AROC
O	1909	1910	,
O	1911	1912	0
O	1912	1913	.
O	1913	1915	91
O	1915	1916	)
O	1917	1920	and
B-Disease	1921	1929	glaucoma
I-Disease	1930	1938	suspects
O	1939	1940	(
O	1940	1944	AROC
O	1944	1945	,
O	1946	1947	0
O	1947	1948	.
O	1948	1950	67
O	1950	1951	)
O	1951	1952	.

O	1953	1955	It
O	1956	1960	also
O	1961	1964	had
O	1965	1968	the
O	1969	1978	strongest
O	1979	1990	correlation
O	1991	1995	with
B-Characteristic	1996	2002	visual
I-Characteristic	2003	2011	function
O	2012	2013	(
O	2013	2014	r
O	2015	2016	=
O	2017	2018	0
O	2018	2019	.
O	2019	2021	60
O	2021	2022	/
O	2022	2024	R2
O	2025	2026	=
O	2027	2028	0
O	2028	2029	.
O	2029	2031	36
O	2031	2032	,
O	2033	2034	P
O	2035	2036	<
O	2037	2038	0
O	2038	2039	.
O	2039	2042	001
O	2042	2043	)
O	2043	2044	.

B-Characteristic	2045	2052	Macular
I-Characteristic	2053	2056	NFL
I-Characteristic	2057	2066	thickness
O	2067	2070	was
O	2071	2084	significantly
O	2085	2092	reduced
O	2093	2095	in
B-Disease	2096	2104	glaucoma
O	2104	2105	.

O	2106	2108	It
O	2109	2112	had
O	2113	2114	a
O	2115	2122	similar
O	2123	2137	discriminating
O	2138	2143	power
O	2144	2147	for
B-Disease	2148	2156	glaucoma
O	2157	2166	detection
O	2167	2170	but
O	2171	2172	a
O	2173	2181	stronger
O	2182	2193	correlation
O	2194	2198	with
B-Characteristic	2199	2205	visual
I-Characteristic	2206	2214	function
O	2215	2219	than
B-Characteristic	2220	2225	total
I-Characteristic	2226	2233	macular
I-Characteristic	2234	2243	thickness
O	2243	2244	.

B-Characteristic	2245	2258	Peripapillary
I-Characteristic	2259	2262	NFL
I-Characteristic	2263	2272	thickness
O	2272	2273	,
O	2274	2281	however
O	2281	2282	,
O	2283	2295	outperformed
O	2296	2300	both
B-Characteristic	2301	2306	total
I-Characteristic	2307	2314	macular
I-Characteristic	2315	2318	and
I-Characteristic	2319	2326	macular
I-Characteristic	2327	2330	NFL
I-Characteristic	2331	2340	thickness
O	2341	2343	in
O	2344	2349	terms
O	2350	2352	of
B-Disease	2353	2361	glaucoma
O	2362	2371	detection
O	2372	2375	and
B-Characteristic	2376	2382	visual
I-Characteristic	2383	2391	function
O	2392	2403	correlation
O	2403	2404	.

B-Characteristic	2405	2418	Peripapillary
I-Characteristic	2419	2422	NFL
I-Characteristic	2423	2432	thickness
O	2432	2433	,
O	2434	2436	as
O	2437	2438	a
B-Characteristic	2439	2444	total
I-Characteristic	2445	2456	measurement
I-Characteristic	2457	2459	of
I-Characteristic	2460	2464	both
I-Characteristic	2465	2472	macular
I-Characteristic	2473	2476	and
I-Characteristic	2477	2487	peripheral
I-Characteristic	2488	2491	NFL
O	2491	2492	,
O	2493	2495	is
O	2496	2501	still
O	2502	2505	the
O	2506	2510	best
O	2511	2520	surrogate
O	2521	2527	marker
O	2528	2530	in
B-Disease	2531	2539	glaucoma
O	2540	2550	assessment
O	2550	2551	.
